publictrace
Search free ↗ Dashboard ↗
Company profile / CA

Amgen

PublicTrace currently links 390 federal records across 12 source groups to this company, spanning 2013-07-03 through 2026-10-11. The largest record category is securities disclosures. Inspect sample evidence and follow the original agency links before using a record in a consequential decision.

Federal records390
Federal source groups12
Reported stateCA
Entityent_d76df3d9f1d458d0
Open federal vendor evidence report ↗

Selected public evidence

DOJ · SEC · EPAFederal enforcement actions9

actions · 2013-07-03 to 2025-03-26

 OSHA · DOLWorkplace safety & labor2

records · 2024-04-09 to 2024-08-29

 EPAEnvironmental record2

records · 2024-01-01 to 2024-01-01

 LDAFederal lobbying46

filings · 2016-01-20 to 2026-01-20

 SECSecurities disclosures178

filings · 2017-02-14 to 2026-10-11

4 additional source groups are available in the complete history.

Sample federal records

Showing up to five records from selected enforcement, operating-history, lobbying, disclosure, and restricted-party categories. This is not an exhaustive search.

DOJ · SEC · EPA

Federal enforcement actions

Showing 5 of 9

  1. Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. FDA · Enforcement Why linked: Attributed by a source-name match; verify the named party.
    View on openFDA ↗
  2. Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. FDA · Enforcement Why linked: Attributed by a source-name match; verify the named party.
    View on openFDA ↗
  3. Amgen Inc. and Horizon Therapeutics plc, FTC v. FTC · Enforcement Why linked: Attributed by a source-name match; verify the named party.
    FTC case page ↗
  4. Defective container: loose crimp defect, potential loss of container integrity. FDA · Enforcement Why linked: Attributed by a source-name match; verify the named party.
    View on openFDA ↗
  5. Celadon Group, Inc. Enters into Corporate Resolution for Securities Fraud and Agrees to Pay $42.2 Million in Restitution (dpa, plea) DOJ · Enforcement Why linked: Attributed by a source-name match; verify the named party.
    DOJ press release ↗
OSHA · DOL

Workplace safety & labor

Showing 2 of 2

  1. OSHA Other violation (citation 01001) — penalty $3,000.00 OSHA · Violation Why linked: Attributed through the establishment record; verify the named party.
    OSHA inspection detail ↗
  2. OSHA inspection of AMGEN INC. (activity 347399990) OSHA · Inspection Why linked: Attributed through the establishment record; verify the named party.
    OSHA inspection detail ↗
EPA

Environmental record

Showing 2 of 2

  1. TRI report for AMGEN MANUFACTURING LTD LLC (2024)

    Toxics release filing — facility AMGEN MANUFACTURING LTD LLC

    EPA · Release Report Why linked: Attributed through PublicTrace entity resolution; verify the named party.
    View original source ↗
  2. TRI report for IMMUNEX RHODE ISLAND CORP A SUBSIDIARY OF AMGEN INC (2024)

    Toxics release filing — facility IMMUNEX RHODE ISLAND CORP A SUBSIDIARY OF AMGEN INC

    EPA · Release Report Why linked: Attributed through PublicTrace entity resolution; verify the named party.
    View original source ↗
LDA

Federal lobbying

Showing 5 of 46

  1. Lobbying — 4th Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $3,550,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.
    Senate LDA filing ↗
  2. Lobbying — 3rd Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $3,550,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.
    Senate LDA filing ↗
  3. Lobbying — 2nd Quarter - Amendment (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $2,580,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.
    Senate LDA filing ↗
  4. Lobbying — 2nd Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $2,580,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.
    Senate LDA filing ↗
  5. Lobbying — 1st Quarter - Report (CPT; HCR; MMM; TAR; TAX) via AMGEN, INC. — $3,610,000 LDA · Lobbying Filing Why linked: Attributed by a source-name match; verify the named party.
    Senate LDA filing ↗
SEC

Securities disclosures

Showing 5 of 178

  1. Registration SEC · Registration Why linked: Linked by SEC CIK 0000318154.
    Source link unavailable
  2. 3 filing

    Form 3 - Initial statement of beneficial ownership of securities

    SEC · Filing Why linked: Linked by SEC CIK 0000318154.
    View original source ↗
  3. 4 filing

    Form 4 - Statement of changes in beneficial ownership of securities

    SEC · Filing Why linked: Linked by SEC CIK 0000318154.
    View original source ↗
  4. 4 filing

    Form 4 - Statement of changes in beneficial ownership of securities

    SEC · Filing Why linked: Linked by SEC CIK 0000318154.
    View original source ↗
  5. 144 filing

    Form 144 - Report of proposed sale of securities

    SEC · Filing Why linked: Linked by SEC CIK 0000318154.
    View original source ↗

These records are currently attributed to Amgen through PublicTrace’s entity-resolution process. Verify the named party and original source before relying on a match. An absent category is not proof that no relevant record exists.

371 additional records · Complete history adds every source group, date/source filters, exports, saved monitoring, and API access.

Open all 390 records ↗ Open all 390 records ↗

Related companies

Gilead SciencesCAModernaMAAdobeCAAMDCAAirbnbCAAppleCAChevronCACiscoCA